IGF-1R binding proteins and antagonists

Details for Australian Patent Application No. 2008244496 (hide)

Owner Novo Nordisk A/S Antyra Inc.

Inventors Schaffer, Lauge; Fletcher, Paul; Spetzler, Jane; Ostergaard, Soren; Mathiasen, Ida heise Stenfeldt; Goldstein, Neil L.; Pillutla, Renuta

Agent FB Rice

Pub. Number AU-A-2008244496

PCT Pub. Number WO2008/133961

Priority 60/925,982 24.04.07 US

Filing date 23 April 2008

Wipo publication date 6 November 2008

International Classifications

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

Event Publications

19 November 2009 PCT application entered the National Phase

  PCT publication WO2008/133961 Priority application(s): WO2008/133961

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008244511-Dual-acting antihypertensive agents

2008244495-An aperture system with spatiallybiased aperture shapes for 3-D defocusing-based imaging